"We Can Do More" for children living with blood cancer

“I cried when I found out I could go back to school”

On this episode of Let’s Talk Blood Cancer: The Patients' Podcast, childhood leukaemia survivors Hughie Higginson and Jude Hawkridge share their experiences of being diagnosed with Acute Lymphoblastic Leukaemia (ALL), the challenges of treatment, and how they’ve rebuilt their lives after cancer. They also reflect on the hope the ATICUS Network brings for future generations of children with blood cancer.What’s in this episode:- Hughie and Jude’s experiences of being diagnosed with Acute Lymphoblastic Leukaemia (ALL), including the symptoms they experienced and how long it took to receive a diagnosis- The emotional impact of hearing the word "cancer" as a child and navigating treatment at a young age- Jude’s treatment journey, from chemotherapy and CAR-T cell therapy to receiving a stem cell transplant- The realities of spending long periods in hospital, coping with isolation, missing family and friends, and finding comfort in the small things during treatment- How treatment affected everyday life, including changes in appetite, missing school and football, and the importance of being treated like any other child- The lasting impact Professor Rob Wynn had on both Hughie and Jude’s treatment journeys- Why the ATICUS Network is so important in developing less toxic treatments, expanding access to innovative clinical trials, and improving outcomes for children undergoing stem cell transplantsFind out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: https://www.cureleukaemia.co.uk/ [https://www.cureleukaemia.co.uk/]

"The bottom falls out of their world"

On this episode of Let’s Talk Blood Cancer, we are joined by Dr. Katharine Patrick, Consultant Paediatric Haematologist at Sheffield Children’s Hospital, to explore the realities of treating children with blood cancer, supporting families through diagnosis, and the exciting advances shaping the future of paediatric care and research.What’s in this episode:- Dr. Patrick’s journey into medicine and how a six-month placement inspired her to specialise in paediatric haematology- The emotional challenges and rewards of caring for children with blood cancer, and the importance of the multidisciplinary team supporting patients and families- How childhood leukaemia is diagnosed and common symptoms- The conversations doctors have with families following a diagnosis, including providing reassurance, hope, and tailored support throughout treatment- Why exercise is becoming an increasingly important part of childhood cancer care, helping children recover more quickly and maintain their long-term health- Katharine's fundraising challenge, cycling The Route (all stages of the Tour de France Femmes Avec Zwift) and why funding research is essential- The importance of the ATICUS Network in expanding access to clinical trials, accelerating new treatments for children undergoing stem cell transplants, and improving supportive careFind out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: https://www.cureleukaemia.co.uk/ [https://www.cureleukaemia.co.uk/]

"We Can Do More" for children living with blood cancer

On this episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Rob Wynn, Consultant Paediatric Haematologist and Director of Blood and Bone Marrow Transplantation at Manchester Children’s Hospital.What’s in this episode:- Rob’s journey into medicine and how a last-minute decision at sixth form led him to a career in paediatric haematology- Why haematology appealed to him as a specialty, combining both the science and philosophy of medicine- The remarkable advances he has witnessed in childhood blood cancer treatment during more than 30 years in the field- Why giving families hope, alongside honesty, is essential when a child is diagnosed with leukaemia- What a true cure means to Rob, and the importance of helping children live healthy, normal lives after treatment- The role of blood and bone marrow transplantation in treating childhood blood cancers and the potential of cord blood donations- How immunotherapy, targeted treatments and transplantation are creating new options when chemotherapy alone is not enough- The motivation that continues to drive his work, including improving outcomes and reducing treatment-related side effects- His vision for the future through the ATICUS Network, with a focus on curing every child while minimising toxicity- The story behind completing Tour 21 despite breaking his elbow on day two, and why supporting blood cancer research remains so importantFind out more about Cure Leukaemia and how you can support pioneering blood cancer research and patients across the globe: https://www.cureleukaemia.co.uk/ [https://www.cureleukaemia.co.uk/]

"We Were An Hour From Going Bust"

On this episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by James McLaughlin, Chief Executive of Cure Leukaemia. What’s in this episode: * James’ route into Cure Leukaemia, from his career in sport with organisations including Nike, Watford FC and Edgbaston Cricket Club * How meeting Cure Leukaemia co-founders Professor Charlie Craddock and Graham Silk inspired him to join the charity’s mission * Why his commercial and marketing background has helped drive the charity’s growth and fundraising success * The importance of keeping patients at the heart of every decision and seeing first-hand the impact of clinical research * The partnerships and fundraising milestones that helped transform Cure Leukaemia * The story behind Tour 21 and the moment Cure Leukaemia came within “an hour of going bust” * James’ vision for the future, including expanding access to clinical trials and growing the ATICUS Network to improve treatment options for children with blood cancer Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠⁠https://www.cureleukaemia.co.uk/⁠ [⁠⁠⁠https://www.cureleukaemia.co.uk/⁠]

How Clinical Trials Are Changing Lives

On this special International Clinical Trials Day episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Chris Fox, Professor of Haematology at Nottingham University Hospitals and Medical Director of the Trials Acceleration Programme (TAP), to discuss the vital role clinical trials play in advancing blood cancer treatment and improving patient outcomes. What’s in this episode: * Professor Fox’s journey into haematology and lymphoma, and the differences between lymphoma and leukaemia * How he balances patient care with leading and designing clinical trials to bring new treatments to patients * Why clinical trials are essential for developing safer and more effective therapies for blood cancers * The major advances transforming lymphoma treatment, including immunotherapy, CAR-T cell therapy, and bispecific antibodies * The impact of the Trials Acceleration Programme (TAP) in improving access to pioneering clinical trials across the UK * Why Professor Fox believes the future of lymphoma treatment is incredibly promising, with continued progress expected over the next decade Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠ [https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqazNPOE5fdnFsX2cxZnQ2bV9lWndKcWkyYTBTUXxBQ3Jtc0ttSEwydUZWZUw1UUZnTmQtQ0gxN1QzVFk4dmhNVGM1UmoxZGF3dXpPLTVaQVQ0ZGkzbmU4UGV0dHZ0QlRyNzM5Y0NMZnZlRGJqSC1IUTNKSElVZUtWMUNyNjNObmlJYUhlT0pRdGFFX1JWRXpjN0lLUQ&q=https%3A%2F%2Fwww.cureleukaemia.co.uk%2F%E2%81%A0&v=tYOjTMsixUs]